Exo Imaging is a company pioneering a high-performance ultrasound platform based on patented Piezoelectric Micromachined Ultrasonic Transducers (pMUT) technology and artificial intelligence (AI) for imaging and therapeutic applications.
Exo (pronounced “Echo”) is bringing diagnostic-grade medical imaging to the pocket of every caregiver and clinician worldwide.
Exo Imaging was founded in 2015 by Sandeep Akkaraju, Janusz Bryzek, Yusuf Haque and John Kokulis. The company is headquartered in Redwood City, California.
Exo is committed to delivering affordable and easy-to-use medical imaging to healthcare professionals around the world. By delivering easy-to-use, high quality medical imaging, Exo will empower healthcare professionals to make critical, real-time decisions that improve patient outcomes.
The Exo ultrasound platform combines advances in nano-materials, novel sensor technologies, advanced signal processing and computation with the economies of scale of semiconductor manufacturing to dramatically reduce the cost of imaging.
Exo is backed by Intel Capital, RA Capital Management, BlackRock, Applied Ventures, Sands Capital, Bold Capital, Longevity Vision Fund, Reimagined Ventures, DK Ventures and others. The company raised $220M in Series C round on Jul 29, 2021. This brings Exo's total funding to $307.6M to date.